Addressing the Cold Reality of mRNA Vaccine Stability

As mRNA vaccines became the frontrunners in late-stage clinical trials to fight the COVID-19 pandemic, challenges surrounding their formulation and stability became readily apparent. In this commentary, we first describe company proposals, based on available public information, for the (frozen) stor...

Descripción completa

Detalles Bibliográficos
Autores principales: Crommelin, Daan J.A., Anchordoquy, Thomas J., Volkin, David B., Jiskoot, Wim, Mastrobattista, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of the American Pharmacists Association. 2021
Materias:
Special Topic Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834447/
https://www.ncbi.nlm.nih.gov/pubmed/33321139
http://dx.doi.org/10.1016/j.xphs.2020.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834447/
https://www.ncbi.nlm.nih.gov/pubmed/33321139
http://dx.doi.org/10.1016/j.xphs.2020.12.006

Ejemplares similares